AC Immune boosts its preclinical Alzheimer's pipeline
14.January 2010 08:00 CET
- In-licensing of promising memory enhancer ACI-518 from State University of Moscow to complement Alzheimer's disease drug pipeline
- Proprietary Morphomer(TM) ACI-636 enters preclinical development